Drug makers expect worse business conditions in 2nd quarter

Korean pharmaceutical companies expect market connditions to be further sluggish over the next three months, according to industry officials.

Korea’s major pharmaceutical firms saw their earnings decline 43 percent for the first quarter of this year due to hurried disposal of drug inventories ahead of government-mandated cuts in drug prices in April 1.

According to the data compiled by Ya...